DAYS
20+
SPEAKERS
30+
SESSION
80+
ATTENDANCE
India Pharma Inc’s next growth phase must be characterised by a shift from volume to value. This, in turn, requires innovation and research capabilities to discover and develop new medicines and therapeutic options for a variety of disease profiles along with a firm commitment to enable accessible and affordable healthcare solutions to patients across the globe.
Hence, FDD Conclave 2024 will focus on the quest for more effective, targeted, and patient-friendly therapeutics, under the theme, ‘Forging the path for tomorrow’s therapeutics. The conclave aims to bring together experts, researchers and thought leaders to explore novel approaches to FR&D and showcase capabilities to develop new molecules, innovative pharma/biopharma products.
The conclave will gather FR&D leaders to discuss how India Pharma Inc can capitalise on its strengths such as technical expertise, cost efficiency, and supportive government policies in its next phase of growth and secure its position in the global pharma R&D landscape.
They will also delve into the advancements, challenges and opportunities in formulation development and drug delivery driven by technological innovation and evolving patient needs.
Through insightful discussions and interactive sessions, the doyens of the FR&D fraternity will cover a plethora of pertinent topics and issues including:
Innovative drug delivery systems (Microneedles, implants, prefilled syringes, self-administered drug delivery systems, transdermal patches etc)
Barriers and challenges such as bioavailability enhancement, solubility issues, stability challenges, excipient selection, lab to market scalability, regulatory approvals etc
Emerging technologies and their applications in FR&D
Patient-centric design for formulation. and delivery to improve therapeutic outcomes
Approaches to build a more cohesive and collatiocative ecosystem between academia, industry and regulatory agencies
Windows of opportunities to accelerate the development and commercialisation of next gen therapeutics
Thus, FDD Conclave 2024 will facilitate progress in the FR&D and contribute through creation of intellectual property, development of novel solutions to address unmet medical needs, enhancement of patient care
VP, Formulation Development (PDU), Recipharm Pharmaservices
Senior VP, Head - Clinical Development & Medical Affairs, Hetero Labs)
VP, Head of Research and Development - Peptides & Complex API's, Alembic Pharmaceuticals
VP, R&D, Lyrus Life Sciences
Regional Sales Manager, Harro Hoefliger
Head, Process Technology & Support, ACG
MD, Nitika Pharmaceuticals Specialties
Technical Expert, Sigachi Industries
Senior VP - Formulation R&D, Lee Pharma
VP, Delivery Manager - Formulation R&D Oral solids, Dr Reddy's Laboratories
Pharmaceutical Consultant and NMIMS - visiting faculty Quality & Regulatory Affairs
VP R&D, CuraTeQ Bilogics
Chief Technical Officer, Cilicant
AGM - Business Development (Pharma), Cilicant
Associate President, Mankind Pharma
VP, Pharmaceutical R&D, Lupin
Co-founder, MD, Board of Directors, Rubicon Research
Angel Investor (Pharma)
Application Specialist, Equitron Medica
VP- Pharma SGI R&D Head (Injectable), Biological E
Senior Scientist, Merck Life Sciences
Executive Director, VerGo Pharma
VP, Delivery Manager-Inhalation and Head - Process Engineering, Dr Reddy's Laboratories
VP and Head-Biopharmaceutics, Preclin and Clinical Bioanal., Global Clinical Management, Dr Reddy's Laboratories
President - R&D Formulation, Cadila Pharmaceuticals
Director and Executive VP (Technical Operations), Natco Pharma
GM and Head of Downstream and Formulation, BSV
VP and Head – R&D, Axxlent Pharma Science
EVP, MSN Laboratories
Pharmaceutical Formulation Development
Product Development
Pharmaceutical R&D
Technology Transfer
Process Development
Drug Delivery
Delivery Technology
Conference featuring Subject Matter Experts, Industry Veterans, Partner Presentations Slots
Tracks and Sessions that relate to your business
Brand exposure through multiple Digital opportunities and several event exclusive tie-ins
Pair your session with Guest Speaker/leading CXOs
Multimedia campaign providing a solid buildup to the event, supported by a team of tele-callers
Complete peace of mind knowing this is from Express Pharma and the Indian Express Group
Access to database of all attendees for the entire conference (to select sponsors)
Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus). Besides this, we bring out periodic specials like the quarterly Pharma Technology Review, Packaging Special and LABNEXT.
